Effect of b-alanine treatment on mitochondrial taurine level and 5-taurinomethyluridine content
MetadataShow full item record
AbstractBackground: The b-amino acid, taurine, is a nutritional requirement in some species. In these species, the depletion of intracellular stores of taurine leads to the development of severe organ dysfunction. The basis underlying these defects is poorly understood, although there is some suggestion that oxidative stress may contribute to the abnormalities. Recent studies indicate that taurine is required for normal mitochondrial protein synthesis and normal electron transport chain activity; it is known that defects in these events can lead to severe mitochondrial oxidative stress. The present study examines the effect of taurine deficiency on the first step of mitochondrial protein synthesis regulation by taurine, namely, the formation of taurinomethyluridine containing tRNA.
Methods: Isolated rat cardiomyocytes were rendered taurine deficient by incubation with medium containing the taurine transport inhibitor, b-alanine. The time course of cellular and mitochondrial taurine depletion was measured. The primer extension method was employed to evaluate the effect of b-alanine treatment on taurinomethyluridine content of tRNALeu. The protein levels of ND6 were also determined by Western blot analysis.
Results: b-alanine caused a time-dependent decrease in cellular taurine content, which were reduced in half after 48 hrs of incubation. The amount of taurine in the mitochondria was considerably less than that in the cytosol and was unaffected by b-alanine treatment. Approximately 70% of the tRNALeu in the untreated cell lacked taurinomethyluridine and these levels were unchanged following b-alanine treatment. Protein content of ND6, however, was significantly reduced after 48 hours incubation with b-alanine.
Conclusions: The taurine levels of the cytosol and the mitochondria are not directly coupled. The b-alaninemediated reduction in taurine levels is too small to affect taurinomethyluridine levels. Nonetheless, it interferes with mitochondrial protein synthesis, as exemplified by a decrease in ND6 protein content. Thus, b-alanine does not cause alterations in mitochondrial protein synthesis through the lowering of taurine levels.
CitationJ Biomed Sci. 2010 Aug 24; 17(Suppl 1):S25
- Mechanism underlying the antioxidant activity of taurine: prevention of mitochondrial oxidant production.
- Authors: Jong CJ, Azuma J, Schaffer S
- Issue date: 2012 Jun
- Mitochondrial defects associated with β-alanine toxicity: relevance to hyper-beta-alaninemia.
- Authors: Shetewy A, Shimada-Takaura K, Warner D, Jong CJ, Mehdi AB, Alexeyev M, Takahashi K, Schaffer SW
- Issue date: 2016 May
- Role of taurine in the pathologies of MELAS and MERRF.
- Authors: Schaffer SW, Jong CJ, Ito T, Azuma J
- Issue date: 2014 Jan
- Taurine as a constituent of mitochondrial tRNAs: new insights into the functions of taurine and human mitochondrial diseases.
- Authors: Suzuki T, Suzuki T, Wada T, Saigo K, Watanabe K
- Issue date: 2002 Dec 2
- Shape and size changes induced by taurine depletion in neonatal cardiomyocytes.
- Authors: Schaffer SW, Ballard-Croft C, Azuma J, Takahashi K, Kakhniashvili DG, Jenkins TE
- Issue date: 1998